Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

被引:6
|
作者
Marin-Romero, Samira [1 ]
Elias-Hernandez, Teresa [1 ]
Isabel Asensio-Cruz, Maria [1 ]
Ortega-Rivera, Rocio [1 ]
Morillo-Guerrero, Raquel [2 ]
Toral, Javier [3 ]
Montero, Emilio [3 ]
Sanchez, Veronica [4 ]
Arellano, Elena [4 ]
Sanchez-Diaz, Jose Maria [1 ]
Real-Dominguez, Macarena [5 ]
Otero-Candelera, Remedios [1 ]
Jara-Palomares, Luis [1 ,6 ]
机构
[1] Hosp Univ Virgen Rocio, Unidad Med Quirurg Enfermedades Resp, Seville, Spain
[2] Hosp Ramon & Cajal, Serv Neumol, Madrid, Spain
[3] Hosp Univ Virgen Rocio, Unidad Urgencias & Emergencias, Seville, Spain
[4] Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[5] Univ Malaga, Dept Med Prevent & Salud Publ, Malaga, Spain
[6] Inst Salud Carlos III, CIBERES, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2019年 / 55卷 / 12期
关键词
Decision support techniques; Venous thromboembolism; Validation studies (Publication type); Pulmonary embolism; Venous thrombosis; ACUTE PULMONARY-EMBOLISM; ANTITHROMBOTIC THERAPY; DIAGNOSIS; THROMBOSIS; DURATION; RATES; RULE; COHORT; MODEL;
D O I
10.1016/j.arbres.2019.03.025
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Scales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months. Methods: This was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration). Results: Of 353 patients evaluated, 195 were analyzed, with an average age of 53.5 +/- 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p < .05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p < .05). Conclusions: Our study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). (C) 2019 SEPAR. Published by Elsevier Espana. S.L.U. All rights reserved.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 50 条
  • [1] Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score
    Tosetto, Alberto
    Iorio, Alfonso
    Marcucci, Maura
    Baglin, Trevor
    Cushman, Mary
    Eichinger, Sabine
    Palareti, Gualtiero
    Poli, Daniela
    Tait, Campbell R.
    Douketis, James D.
    BLOOD, 2011, 118 (21) : 251 - 252
  • [2] A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (damoves)
    Moreno, A. I. F.
    Navarro, M. J. G.
    Sanchez, J. O.
    Diaz, R. M. M.
    Cerezo, E. M.
    de Ancos Aracil, C. L.
    Diaz, V. M.
    Garcia, A. G.
    Hernandez, C. M.
    Arponen, S.
    Clotet, N. C.
    Giardin, J. M. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 682 - 682
  • [3] Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data
    Marcucci, M.
    Iorio, A.
    Douketis, J. D.
    Eichinger, S.
    Tosetto, A.
    Baglin, T.
    Cushman, M.
    Palareti, G.
    Poli, D.
    Tait, R. C.
    Kyrle, P. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (05) : 775 - 781
  • [4] A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)
    Franco Moreno, A. I.
    Garcia Navarro, M. J.
    Ortiz Sanchez, J.
    Martin Diaz, R. M.
    Madronal Cerezo, E.
    de Ancos Aracil, C. L.
    Cabello Clotet, N.
    Perales Fraile, I.
    Gimeno Garcia, S.
    Montero Hernandez, C.
    Zapatero Gaviria, A.
    Ruiz Giardin, J. M.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 29 : 59 - 64
  • [5] Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
    Tosetto, A.
    Iorio, A.
    Marcucci, M.
    Baglin, T.
    Cushman, M.
    Eichinger, S.
    Palareti, G.
    Poli, D.
    Tait, R. C.
    Douketis, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : 1019 - 1025
  • [6] Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model
    Tritschler, Tobias
    Mean, Marie
    Limacher, Andreas
    Rodondi, Nicolas
    Aujesky, Drahomir
    BLOOD, 2015, 126 (16) : 1949 - 1951
  • [7] Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score
    Bertoletti, L.
    Robin, P.
    Jara-Palomares, L.
    Tromeur, C.
    Pastre, J.
    Prevot-Bitot, N.
    Mouneh, T.
    Le Gal, G.
    Salaun, P. -Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (11) : 2184 - 2187
  • [8] PREDICTING RECURRENCE IN ELDERLY PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM: PROSPECTIVE VALIDATION OF THE UPDATED VIENNA PREDICTION MODEL
    Tritschler, Tobias
    Mean, Marie
    Limacher, Andreas
    Rodondi, Nicolas
    Aujesky, Drahomir
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 : S232 - S232
  • [9] Utility of a recurrence prediction tool (DASH score) at a single centre after unprovoked venous thromboembolism: patient uptake of the tool and short term risks of stopping anticoagulation
    W. Thomas
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 971 - 973
  • [10] Utility of a recurrence prediction tool (DASH score) at a single centre after unprovoked venous thromboembolism: patient uptake of the tool and short term risks of stopping anticoagulation
    Thomas, W.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 971 - 973